| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.08B | +33.2% |
| Cost of Revenue | $841.1M | +38.3% |
| Gross Profit | $1.24B | +29.9% |
| R&D Expense | $441.6M | +45.4% |
| SG&A Expense | $741.2M | +49.2% |
| Operating Income | $58.5M | -62.2% |
| Pre-tax Income | $381.5M | +146.1% |
| Income Tax | $4.5M | +123.2% |
| Net Income | $377.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $454.8M | -24.0% |
| Short-term Investments | $333.2M | -48.3% |
| Inventory | $265.3M | -1.7% |
| Current Assets | $2.30B | -4.1% |
| Total Assets | $4.47B | +30.2% |
| Current Liabilities | $1.68B | +109.7% |
| Long-term Debt | $0 | -100.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $408.3M | +115.7% |
| Capital Expenditures | $78.8M | +32.1% |
| Investing Cash Flow | -$490.6M | -4032.1% |
| Financing Cash Flow | -$45.4M | -210.0% |
| Free Cash Flow | $329.5M | +154.2% |
| +116.4% |
| EPS (Basic) | $4.98 | +111.9% |
| EPS (Diluted) | $4.80 | +107.8% |
| Total Liabilities |
| $2.15B |
| +17.7% |
| Stockholders' Equity | $2.33B | +44.4% |